MedPath

Therapeutic apps for control drinking or abstinence: A feasibility randomized controlled study

Phase 2
Conditions
alcohol dependence
D000437
Registration Number
JPRN-jRCTs062210005
Lead Sponsor
OUSO Kazuhiro
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

1.A person who is 20 years of age or older at the time of obtaining the consent
2.A person diagnosed with alcohol dependence
3.A person who has high or very high DRL (average daily alcohol intake is more than 60g for men and 40g for women during the past 14 days at each time point) both at screening and at the start of the intervention
4.A person who could be treated in an outpatient setting
5.A person who has not had serious difficulties in social and family life caused by drinking
6.A person who has not had life-threatening or serious organ damage because of drinking
7.A person who has not had alcohol withdrawal symptoms (such as hallucinations, convulsions, and tremors) that require any urgent treatments
8.A person who has given the consents for participating in this study by their free will after being fully informed and understanding about this study
9.A person who can communicate with clinical trial staffs
10.A person who is willing to undergo the intervention at predetermined times and procedures and use the device under study
11. A person who uses smartphone on a daily basis

Exclusion Criteria

1.A person who had less than 6 heavy drinking days (HDDS: days drinking more than 60g for men and 40g for women ) in the four weeks before screening
2.A person who had five consecutive days with not drinking alcohol in the four weeks before screening
3.A person who underwent alcohol dependence treatment or participated in the support program for reducing alcohol intake or self-help group in the 4 weeks before screening
4.A person who received other structured psychotherapy in the four weeks before screening
5.A person with the complications of dementia and intellectual disability
6.A person who took concomitant prohibited drugs in the 4 weeks before screening
7.A person with a significant suicidal ideation at screening or at the start of the intervention
8.A person determined to have significant suicide risk by the principal investigator or sub-physician
9.A person who participated in any clinical trials in the four weeks before screening
10.A person who does not have a fixed address and phone number
11.A person who does not use an iPhone with iOS14.0 or later or Android with version 10 or later on a daily basis
12.A person who the principal investigator or sub-physician considered unsuitable as a subject.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath